3-Pyridinecarbonitrile, 2-[4-[2-[[(2S)-2-hydroxy-3-[2-(2-thienyl)phenoxy]propyl]amino]-2-methylpropyl]phenoxy]-, (2E)-2-butenedioate (2:1) (salt) manufacturers
|
| | 3-Pyridinecarbonitrile, 2-[4-[2-[[(2S)-2-hydroxy-3-[2-(2-thienyl)phenoxy]propyl]amino]-2-methylpropyl]phenoxy]-, (2E)-2-butenedioate (2:1) (salt) Basic information |
| | 3-Pyridinecarbonitrile, 2-[4-[2-[[(2S)-2-hydroxy-3-[2-(2-thienyl)phenoxy]propyl]amino]-2-methylpropyl]phenoxy]-, (2E)-2-butenedioate (2:1) (salt) Chemical Properties |
| | 3-Pyridinecarbonitrile, 2-[4-[2-[[(2S)-2-hydroxy-3-[2-(2-thienyl)phenoxy]propyl]amino]-2-methylpropyl]phenoxy]-, (2E)-2-butenedioate (2:1) (salt) Usage And Synthesis |
| Uses | Lubabegron (LY-488756) fumarate is an antagonist of the adrenergic receptor (β-AR). Lubabegron fumarate can antagonize the stimulatory effects of β1-AR and β2-AR agonists on lipase respectively[1]. | | References | [1] Hwang JH, et al. Lubabegron fumarate acts as a β-adrenergic receptor antagonist in cultured bovine intramuscular and subcutaneous adipocytes. J Anim Sci. 2022 Mar 1;100(3):skac052. DOI:10.1093/jas/skac052 |
| | 3-Pyridinecarbonitrile, 2-[4-[2-[[(2S)-2-hydroxy-3-[2-(2-thienyl)phenoxy]propyl]amino]-2-methylpropyl]phenoxy]-, (2E)-2-butenedioate (2:1) (salt) Preparation Products And Raw materials |
|